Imagine you are suffering from depression. Your psychiatrist puts you on a well-known anti-depressant of which millions of doses are prescribed every year, around the world. But you feel worse than ever before. You even receive a professional setback owing to the drug’s side effects. The psychiatrist is perplexed because she had chosen a drug based on well-designed, fair trials, with overwhelmingly positive results. What could be wrong? Interestingly, sometime later, your doctor comes across an uncustomary study conducted by a group of researchers. They have discovered that for all the antidepressants that came to the market in the last fifteen years, only half the clinical trials were published in full – the ones with positive results for the drugs. The ones with negative results were simply lost to history, never appearing anywhere other than in the dusty, disorganized, files of the FDA. A few of the negative trials did appear in academic literature, but were writte...